Conduit Pharmaceuticals Inc (CDT) concluded trading on Wednesday at a closing price of $0.78, with 3.37 million shares of worth about $2.63 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -92.82% during that period and on April 16, 2025 the price saw a loss of about -12.97%. Currently the company’s common shares owned by public are about 9.55M shares, out of which, 8.35M shares are available for trading.
Stock saw a price change of 25.82% in past 5 days and over the past one month there was a price change of -19.94%. Year-to-date (YTD), CDT shares are showing a performance of -88.63% which decreased to -99.76% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.51 but also hit the highest price of $350.00 during that period. The average intraday trading volume for Conduit Pharmaceuticals Inc shares is 5.55 million. The stock is currently trading -1.74% below its 20-day simple moving average (SMA20), while that difference is down -29.73% for SMA50 and it goes to -92.96% lower than SMA200.
Conduit Pharmaceuticals Inc (NASDAQ: CDT) currently have 9.55M outstanding shares and institutions hold larger chunk of about 0.85% of that.
The stock has a current market capitalization of $7.45M and its 3Y-monthly beta is at 2.17. It has posted earnings per share of -$21.28 in the same period. It has Quick Ratio of 0.25. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CDT, volatility over the week remained 42.79% while standing at 24.60% over the month.
